167 related articles for article (PubMed ID: 21514198)
1. Radiobiological rationale and clinical implications of hypofractionated radiation therapy.
Ko EC; Forsythe K; Buckstein M; Kao J; Rosenstein BS
Cancer Radiother; 2011 Jun; 15(3):221-9. PubMed ID: 21514198
[TBL] [Abstract][Full Text] [Related]
2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
3. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
Marcu LG
Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionation in adjuvant breast radiotherapy.
Khan A; Haffty BG
Breast; 2010 Jun; 19(3):168-71. PubMed ID: 20511065
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionation for prostate cancer: a critical review.
Miles EF; Lee WR
Semin Radiat Oncol; 2008 Jan; 18(1):41-7. PubMed ID: 18082587
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience using hypofractionated radiation schedules in breast cancer.
Whelan TJ; Kim DH; Sussman J
Semin Radiat Oncol; 2008 Oct; 18(4):257-64. PubMed ID: 18725113
[TBL] [Abstract][Full Text] [Related]
7. Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy.
Théberge V; Whelan T; Shaitelman SF; Vicini FA
Semin Radiat Oncol; 2011 Jan; 21(1):55-65. PubMed ID: 21134655
[TBL] [Abstract][Full Text] [Related]
8. Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation.
Kavanagh BD; Miften M; Rabinovitch RA
Cancer J; 2011; 17(3):177-81. PubMed ID: 21610471
[TBL] [Abstract][Full Text] [Related]
9. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated radiation therapy versus conventional radiation therapy in prostate cancer: A systematic review of its safety and efficacy.
Sánchez-Gómez LM; Polo-deSantos M; Rodríguez-Melcón JI; Angulo JC; Luengo-Matos S
Actas Urol Esp; 2015; 39(6):367-74. PubMed ID: 25660427
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system.
Aneja S; Pratiwadi RR; Yu JB
Oncology (Williston Park); 2012 Jun; 26(6):512-8. PubMed ID: 22870533
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery.
Holloway CL; Panet-Raymond V; Olivotto I
Breast; 2010 Jun; 19(3):163-7. PubMed ID: 20511064
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated radiotherapy in prostate cancer.
Vavassis P; Nguyen DH; Bahary JP; Yassa M
Expert Rev Anticancer Ther; 2012 Jul; 12(7):965-72. PubMed ID: 22845411
[TBL] [Abstract][Full Text] [Related]
14. External beam irradiation for localized prostate cancer--the promise of hypofractionation.
Loblaw DA; Cheung P
Can J Urol; 2006 Feb; 13 Suppl 1():62-6. PubMed ID: 16526985
[TBL] [Abstract][Full Text] [Related]
15. Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy.
Gay HA; Sibata CH; Allison RR; Jeremic B
Radiother Oncol; 2009 Jun; 91(3):369-78. PubMed ID: 19058867
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial.
Yeoh EE; Holloway RH; Fraser RJ; Botten RJ; Di Matteo AC; Butters J; Weerasinghe S; Abeysinghe P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1072-83. PubMed ID: 16965866
[TBL] [Abstract][Full Text] [Related]
17. The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: observations on efficacy and toxicity in clinical practice.
Nedzi LA
Semin Radiat Oncol; 2008 Oct; 18(4):265-72. PubMed ID: 18725114
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer.
Koukourakis MI
Semin Oncol; 2002 Dec; 29(6 Suppl 19):42-6. PubMed ID: 12577243
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of hypofractionated radiotherapy and conventional fractionated radiotherapy in the management of carcinoma of the cervix in Ibadan, Nigeria.
Campbell OB; Akinlade IB; Arowojolu A; Babarinsa IA; Agwimah RI; Adewole IF
Afr J Med Med Sci; 2000; 29(3-4):253-8. PubMed ID: 11714001
[TBL] [Abstract][Full Text] [Related]
20. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience.
Koukourakis MI; Touloupidis S; Manavis J; Abatzoglou I; Sismanidou K; Sivridis L
Anticancer Res; 2004; 24(5B):3239-43. PubMed ID: 15510617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
